Nakagawa Katsuhiro, Yasumitu Tsutomu, Fukuhara Kenjirou, Shiono Hiroyuki, Kikui Masanori
Department of Surgery, Osaka Prefectural Habikino Hospital, Habikino, Osaka, Japan.
Ann Thorac Surg. 2003 Jun;75(6):1740-4. doi: 10.1016/s0003-4975(03)00022-5.
We evaluated the prognosis of adenosquamous carcinoma of the lung after lung resection in comparison with other types of carcinoma.
We retrospectively reviewed charts of patients who underwent lung resection for lung cancer.
Surgical outcomes for 30 patients with adenosquamous carcinoma of the lung, who were treated between 1976 and 1998, were compared with the surgical results for 1,219 patients similarly treated for adenocarcinoma or squamous cell carcinoma during the same period. Adenosquamous carcinoma comprised only 2.1% of 1,408 lung cancer cases treated by resection. The overall cumulative 5-year survival rate was only 6.2% for the patients with adenosquamous carcinoma, indicating a significantly poorer prognosis than for adenocarcinoma or squamous cell carcinoma.
The cumulative survival rate for patients with adenosquamous carcinoma in pathologic stages IA to IIB was similar to that of patients with stage IIIA adenocarcinoma or squamous cell carcinoma.
我们评估了肺切除术后肺腺鳞癌的预后，并与其他类型的肺癌进行比较。
我们回顾性分析了接受肺癌肺切除术患者的病历。
将1976年至1998年间接受治疗的30例肺腺鳞癌患者的手术结果，与同期接受类似治疗的1219例腺癌或鳞癌患者的手术结果进行比较。腺鳞癌仅占1408例接受切除治疗的肺癌病例的2.1%。肺腺鳞癌患者的总体累积5年生存率仅为6.2%，表明其预后明显比腺癌或鳞癌差。
病理分期为IA至IIB期的肺腺鳞癌患者的累积生存率，与IIIA期腺癌或鳞癌患者相似。
